Atea Pharmaceuticals to Present Three Abstracts at EASL 2026 Congress Highlighting Progress Across Viral Hepatitis Pipeline
Go back to Atea Pharmaceuticals to Present Three Abstracts at EASL 2026 Congress Highlighting Progress Across Viral Hepatitis Pipeline| (NASDAQ: AVIR) | Delayed: 4.98 +0.20 (4.18%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.78 | 52 Week High | $2.00 | |||
| Open | $4.78 | 52 Week Low | $1.15 | |||
| Day High | $5.04 | P/E | N/A | |||
| Day Low | $4.78 | EPS | $0.00 | |||
| Volume | 415,177 | |||||

